Matinas BioPharma Holdings, Inc.
MTNB
$0.75
-$0.06-7.19%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.53M | -5.25M | -1.66M | -8.43M | -4.28M |
| Total Depreciation and Amortization | 111.00K | 122.00K | 128.00K | 247.00K | 244.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 253.00K | 3.58M | 21.00K | 4.59M | 968.00K |
| Change in Net Operating Assets | -306.00K | -481.00K | -500.00K | 86.00K | -437.00K |
| Cash from Operations | -1.47M | -2.02M | -2.01M | -3.51M | -3.50M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 320.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 500.00K | 9.65M |
| Cash from Investing | 320.00K | -- | -- | 500.00K | 9.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -1.00K | -1.00K | -1.00K | -2.00K |
| Issuance of Common Stock | 64.00K | -- | -- | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -65.00K |
| Issuance of Preferred Stock | 0.00 | 3.30M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.68M | 1.65M | -- | -- |
| Cash from Financing | 64.00K | 1.62M | 1.65M | -1.00K | -67.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.09M | -399.00K | -360.00K | -3.01M | 6.08M |